LOAMU
MRTX

Lombard Odier Asset Management (USA)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,722
Closed -$1.6M – 219
2015
Q2 		$1.6M Buy
+50,722
New +$1.49M 0.11% 152

Other funds holding MRTX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s MRTX Position: Q3 2015 in Review

Lombard Odier Asset Management (USA) sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2015, closing a stake of 50,722 shares — an estimated $1.6M sold.

Lombard Odier Asset Management (USA) first reported a position in MRTX in Q2 2015 and held it in 1 quarter. The position peaked at $1.6M in Q2 2015. 78 funds tracked by Wall St. Rank hold MRTX as of Q3 2015.

  • Lombard Odier Asset Management (USA) reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 50,722 Mirati Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $1.6M.
  • Lombard Odier Asset Management (USA) first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s Mirati Therapeutics, Inc. Common Stock position peaked at $1.6M in Q2 2015.
  • 78 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2015, filed 16 Nov 2015.